Vertex Pharmaceuticals Inc / Ma
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 91,730 | 0.1% | 202,333 | 12/31/2025 |
| 2025 Q3 | 11/13/2025 | 96,486 | 0.1% | 246,364 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 74,530 | 0.1% | 167,408 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 74,870 | 0.1% | 154,429 | 3/31/2025 |
| 2024 Q4 | 2/13/2025 | 148,739 | 0.1% | 369,354 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 132,085 | 0.1% | 284,004 | 9/30/2024 |
| 2024 Q2 | 8/12/2024 | 158,013 | 0.2% | 337,116 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 161,623 | 0.2% | 386,648 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 145,626 | 0.2% | 357,901 | 12/31/2023 |
| 2023 Q3 | 11/9/2023 | 121,300 | 0.2% | 348,824 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 101,667 | 0.2% | 288,901 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 98,594 | 0.2% | 312,926 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 80,685 | 0.1% | 279,401 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 464,959 | 0.8% | 1,605,854 | 9/30/2022 |
| 2022 Q2 | 8/12/2022 | 464,664 | 0.8% | 1,648,974 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 427,999 | 0.6% | 1,640,031 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 375,155 | 0.4% | 1,708,354 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 307,056 | 0.3% | 1,692,794 | 9/30/2021 |
| 2021 Q2 | 11/16/2021 | 359,456 | 0.4% | 1,782,751 | 6/30/2021 |
| 2021 Q1 | 8/16/2021 | 263,772 | 0.3% | 1,227,475 | 3/31/2021 |
| 2020 Q4 | 2/17/2021 | 12,596 | 0.0% | 53,298 | 12/31/2020 |
| 2020 Q3 | 11/12/2020 | 18,848 | 0.0% | 69,263 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 21,269 | 0.0% | 73,263 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 11,454 | 0.0% | 48,136 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 23,254 | 0.0% | 106,205 | 12/31/2019 |
| 2014 Q1 | 5/9/2014 | 5,248 | 0.0% | 74,214 | 3/31/2014 |
| 2013 Q4 | 2/11/2014 | 7,567 | 0.0% | 101,840 | 12/31/2013 |